Tirzepatide represents a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://jimmweo429439.dbblog.net/13818688/tirzepatide-a-new-frontier-in-diabetes-treatment